课题基金 / 基金详情

Role of heparan sulfate, heparanase inhibitors in the development and prevention of type 1 diabetes

Role of heparan sulfate, heparanase inhibitors in the development and prevention of type 1 diabetes
硫酸乙酰肝素、乙酰肝素酶抑制剂在 1 型糖尿病发生和预防中的作用
批准号:
nhmrc : 418138
负责人:
A/Pr Charmaine Simeonovic
金额:
$216.23万
依托单位国家:
澳大利亚
项目类别:
NHMRC Strategic Awards
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2013-12-31

项目摘要

项目成果

A/Pr Charmaine Simeonovic的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our recent studies have shown that a special protein (an enzyme called heparanase) and the special carbohydrate (heparan sulfate or HS) that it degrades, play a previously unrecognised role in the development of Type I diabetes (T1D) in mice. We will explore whether destructive immune cells use heparanase to damage insulin-producing islets and deplete them of HS, resulting in islet cell death and T1D. We will develop new agents to inhibit this damage, prevent T1D and protect islet transplants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of islet beta cell heparan sulfate in Type 2 diabetes
  • 批准号:
    nhmrc : 1065068
  • 项目类别:
    Project Grants
  • 资助金额:
    $38.46万
  • 财政年份:
    2014
  • 负责人:
    A/Pr Charmaine Simeonovic
  • 依托单位:
Mechanism of protection of islet beta cells from T1D by heparan sulfate
  • 批准号:
    nhmrc : 1043284
  • 项目类别:
    Project Grants
  • 资助金额:
    $40.17万
  • 财政年份:
    2013
  • 负责人:
    A/Pr Charmaine Simeonovic
  • 依托单位:
Major xenoantigens for neovascularised porcine xenografts: the role of PERV and MHC in rejection and tolerance
  • 批准号:
    nhmrc : 224206
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $33.66万
  • 财政年份:
    2003
  • 负责人:
    A/Pr Charmaine Simeonovic
  • 依托单位:
海外基金